Hydroxypropyl methylcellulose-controlled crystallization of erythromycin a dihydrate crystals with modified morphology

Crystal Growth and Design

Volumn 8, Issue 10, 2008, Pages 3526-3531

  Mirza, Sabiruddin ^a   Miroshnyk, Inna ^a   Heinämäki, Jyrki ^a   Rantanen, Jukka ^b   Antikainen, Osmo ^a   Vuorela, Pia ^c   Vuorela, Heikki ^a   Yliruusi, Jouko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61549118137     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg7007599     Document Type: Article

References (27)

1. York, P. Int. J. Pharm. 1983, 14, 1-28.
2. Shekunov, B. Y.; York, P. J. Cryst. Growth 2000, 211, 122-136.
3. York, P. Drug Dev. Ind. Pharm. 1992, 18, 677-721.
4. Berkovitch-Yellin, Z.; van Mil, J.; Addadi, L.; Idelson, M.; Lahav, M.; Leiserowitz, L. J. Am. Chem. Soc. 1985, 107, 3111-3122.
5. Myerson A. S. In Molecular Modeling Applications in Crystallization; Myerson, A. S. Ed.; Cambridge University Press: Cambridge, U.K., 1999; pp 55-105.
6. Davey, R.; Garside J. From molecules to crystallizers: an introduction to crystallization; Oxford University Press: Oxford, 2000.
7. Haleblian, J. K. J. Pharm. Sci. 1975, 64, 1269-1288.
8. Davey, R. J.; Mullin, J. W.; Whiting, M. J. L. J. Cryst. Growth 1982, 58, 304-312.
9. Marshall, P. V.; York, P. Int. J. Pharm. 1989, 55, 257-263.
10. Garekani, H. A.; Sadeghi, F.; Badiee, A.; Mostafa, S. A.; Rajabi-Siahboomi, A. R. Drug Dev. Ind. Pharm. 2001, 27, 803-809.
11. Kuldipkumar, A.; Tan, Y. T. F.; Goldstein, M.; Nagasaki, Y.; Zhang, G. G. Z.; Kwon, G. S. Cryst. Growth Des. 2005, 5, 1781-1785.
12. Rodríguez-Hornedo, N.; Murphy, D. J. Pharm. Sci. 2004, 93, 449-460.
13. Raghavan, S. L.; Trividic, A.; Davis, A. F.; Hadgraft, J. Int. J. Pharm. 2001, 212, 213-221.
14. Stephenson, G. A.; Stowell, J. G.; Pascal, H. T.; Pfeiffer, R. R.; Byrn, S. R. J. Pharm. Sci. 1997, 86, 1239-1244.
15. Mirza, S.; Miroshnyk, I.; Heinämäki, J.; Christiansen, L.; Karjalainen, M.; Yliruusi, J. AAPS PharmSci. 2003, 5(2), Article 12; DOI: 10.1208/ps050212.
16. Miroshnyk, I.; Khriachtchev, L.; Mirza, S.; Rantanen, J.; Heinämäki, J.; Yliruusi, J. Cryst. Growth Des. 2006, 6, 369-74.
17. Zimmermann, A.; Elema, M. R.; Hansen, T.; Müllertz, A.; Hovgaard, L. J. Pharm. Biomed. Anal. 2007, 44, 874-880.
18. Miroshnyk, I.; Mirza, S.; Zorkii, P. M.; Obodovskaya, A. E.; Heinämäki, J.; Yliruusi, J. AAPS PharmSci 2001, 3(S1), Abstract M2221.
19. Katzhendler, I.; Azoury, R.; Friedman, M. J. Controlled Release 1998, 54, 69-85.
20. Wen, H.; Morris, K. R.; Park, K. J. Colloid. Interface Sci. 2005, 290, 325-335.
21. Tian, F.; Sandler, N.; Gordon, K. C.; McGoverin, C. M.; Reay, A.; Strachan, C. J.; Saville, D. J.; Rades, T. Eur. J. Pharm. Biopharm, 2006, 64, 326-335.
22. Riippi, M.; Tanninen, V.; Yliruusi, J. Eur. J. Pharm. Biopharm. 2000, 50, 365-371.
23. Jetzer, W.; Leuenberger, H.; Sucker, H. Pharm. Tech. 1983, 4, 33-39.
24. Bandyopadhyay, R.; Grant, D. J. Pharm. Res. 2002, 19, 491-496.
25. Lee, A. Y.; Myerson, A. S. MRS Bull. 2006, 31, 881-886.
26. Fairbrother, J. E.; Grant, D. J. W. J. Pharm. Pharmacol. 1978, 30, S19.
27. Feng, Y.; Grant, D. J. Pharm. Res. 2006, 23, 1608-1616.